The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 5.16

Cancer of the Cervix Uteri (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2007-2011
Females by Race
Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 16,600 98.1% 12,493 98.2% 2,319 97.6% 1,425 98.3% 123 98.4% 3,646 98.3%
Epidermoid carcinomad (8050-8131) 11,187 66.1% 8,155 64.1% 1,843 77.5% 946 65.3% 78 62.4% 2,530 68.2%
Squamous cell carcinoma (8070) 7,649 45.2% 5,502 43.2% 1,351 56.8% 626 43.2% 56 44.8% 1,563 42.1%
Squamous cell, keratinizing (8071) 1,202 7.1% 874 6.9% 199 8.4% 109 7.5% - - 317 8.5%
Squamous cell, non-keratinizing (8072) 1,508 8.9% 1,147 9.0% 196 8.2% 140 9.7% - - 429 11.6%
Squamous cell, Microinvasive (8076) 567 3.4% 433 3.4% 59 2.5% 50 3.5% - - 157 4.2%
Other (8050-8069, 8073-8075,8077-8131) 261 1.5% 199 1.6% 38 1.6% 21 1.4% - - 64 1.7%
Adenocarcinomae 4,678 27.6% 3,811 30.0% 354 14.9% 420 29.0% 36 28.8% 953 25.7%
Adenocarcinoma, NOS (8140) Adenosquamous (8560,8570) 2,453 14.5% 2,007 15.8% 176 7.4% 217 15.0% - - 501 13.5%
621 3.7% 484 3.8% 64 2.7% 61 4.2% - - 146 3.9%
Other adenocarcinomasf 1,604 9.5% 1,320 10.4% 114 4.8% 142 9.8% - - 306 8.3%
Other specific carcinomasg 249 1.5% 191 1.5% 32 1.3% 21 1.4% - - 55 1.5%
Unspecified, Carcinoma, NOS (8010-8011,8020-8022) 486 2.9% 336 2.6% 90 3.8% 38 2.6% - - 108 2.9%
Sarcomah 61 0.4% 45 0.4% - - - - - - - -
Other specific types (8720-8790,8930-8936, 8950-9030,9060-9110, 9260-9365,9380-9539) 163 1.0% 113 0.9% 32 1.3% 16 1.1% - - 27 0.7%
Unspecified (8000-8005) 97 0.6% 73 0.6% - - - - - - 22 0.6%
Total 16,921 100.0% 12,724 100.0% 2,377 100.0% 1,449 100.0% 125 100.0% 3,709 100.0%

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941.

f Other adenocarcinomas include histologies 8141-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8571-8574,8576,8940-8941.

g Other specific carcinomas include histologies 8012-8015,8030-8046,8150-8155,8170-8175,8230-8249,8508,8510-8513,8561-8562, 8575,8580-8671.

h Sarcoma includes histologies 8680-8713,8800-8921,9040-9044,9120-9136,9150-9252,9370-9373,9540-9582.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.